|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2007-5-28
|
|
pubmed:abstractText |
To investigate whether MHC class II expression on myeloid cells of patients with treatment-naive early rheumatoid arthritis (RA) correlates with disease progression.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1462-0324
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
46
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
931-3
|
|
pubmed:dateRevised |
2007-9-6
|
|
pubmed:meshHeading |
pubmed-meshheading:17384177-Adult,
pubmed-meshheading:17384177-Aged,
pubmed-meshheading:17384177-Antirheumatic Agents,
pubmed-meshheading:17384177-Arthritis, Rheumatoid,
pubmed-meshheading:17384177-Biological Markers,
pubmed-meshheading:17384177-Cell Differentiation,
pubmed-meshheading:17384177-Cells, Cultured,
pubmed-meshheading:17384177-Disease Progression,
pubmed-meshheading:17384177-Female,
pubmed-meshheading:17384177-Follow-Up Studies,
pubmed-meshheading:17384177-HLA-DR Antigens,
pubmed-meshheading:17384177-Humans,
pubmed-meshheading:17384177-Macrophages,
pubmed-meshheading:17384177-Male,
pubmed-meshheading:17384177-Middle Aged,
pubmed-meshheading:17384177-Monocytes,
pubmed-meshheading:17384177-Myeloid Cells,
pubmed-meshheading:17384177-Pilot Projects,
pubmed-meshheading:17384177-Prognosis,
pubmed-meshheading:17384177-Severity of Illness Index,
pubmed-meshheading:17384177-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
MHC class II expression on myeloid cells inversely correlates with disease progression in early rheumatoid arthritis.
|
|
pubmed:affiliation |
Niklaus Fiebiger Center for Molecular Medicine, University of Erlangen-Nuremberg, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
